Sold as Percodan. Every FDA application for this active ingredient: 1 branded and 3 generic.
As of Nov 15, 2026, FDA lists 4 applications for Aspirin; Oxycodone Hydrochloride (sold as Percodan), first approved Apr 12, 1950, with 0 new uses approved and 0 published complete response letters.
| Reduce Opiate Exposure With ACL SurgeryAnterior Cruciate Ligament Injuries · Campbell Clinic | Phase 3 | Enrolling by invitation | Aug 19, 2024 |
| Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension · Duke University | — | Recruiting | Feb 20, 2020 |
| Hip Arthroscopy Postoperative Opioid DemandsOpioid Use, Pain · Rush University Medical Center | Not applicable | Recruiting | Sep 19, 2019 |
| Apr 12, 1950 | Percodan-Demi, PercodanNDA 7337 · New combination | Endo Operations | 31 | Discontinued |
| Mar 16, 2011 | Oxycodone And AspirinANDA 91670 | Dr Reddys Labs SA | 6 | Discontinued |
| Mar 22, 2011 | Oxycodone And AspirinANDA 90084 | Actavis Labs Fl Inc | 10 | Discontinued |
| Jul 16, 2020 | Oxycodone And AspirinANDA 40910 | Epic Pharma LLC | 4 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
